Jove
Visualize
Contact Us

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

147
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
147

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access to obstetric care in rural areas: liability is one of many problems.

Michigan medicine·1990
Same author

Persistence of polybrominated biphenyls (PBB) in human post-mortem tissue.

Environmental health perspectives·1985
Same author

Risk factors for fatal heart attack in young women.

American journal of epidemiology·1981
Same author

Fatal myocardial infarction and the role of oral contraceptives.

American journal of epidemiology·1980
Same author

An estimate of the course of herpes simplex virus encephalitis.

Scandinavian journal of infectious diseases·1976
Same author

Herpes simplex virus encephalitis: therapy trials.

Annals of internal medicine·1973
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 12, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.6K

MDPH biologic products division--a hidden asset

D C Nolan

    Michigan Medicine
    |June 1, 1985
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.6K
    Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
    09:51

    Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

    Published on: May 18, 2018

    11.0K

    Related Experiment Videos

    Last Updated: Dec 12, 2025

    Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
    10:18

    Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

    Published on: July 7, 2023

    1.6K
    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.6K
    Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
    09:51

    Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

    Published on: May 18, 2018

    11.0K